{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:24:35Z","timestamp":1760984675121},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T00:00:00Z","timestamp":1345593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s12094-012-0925-9","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T14:10:27Z","timestamp":1345558227000},"page":"321-326","source":"Crossref","is-referenced-by-count":12,"title":["Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin"],"prefix":"10.1007","volume":"15","author":[{"given":"Jaime","family":"G\u00f3mez-Mill\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Dolores","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Lupia\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Sachetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,22]]},"reference":[{"key":"925_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92\u201398","journal-title":"J Clin Oncol"},{"key":"925_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","volume":"355","author":"JP Pignon","year":"2000","unstructured":"Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949\u2013955","journal-title":"Lancet"},{"key":"925_CR3","doi-asserted-by":"crossref","unstructured":"Pignon JP, le Ma\u00eetre A, Maillard E, Bourhis J, MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4\u201314)","DOI":"10.1016\/j.radonc.2009.04.014"},{"key":"925_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2007.04.002","volume":"85","author":"R Corvo","year":"2007","unstructured":"Corvo R (2007) Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 85:156\u2013170","journal-title":"Radiother Oncol"},{"key":"925_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0b013e32834ea6fe","volume":"24","author":"J Bernier","year":"2012","unstructured":"Bernier J, Horiot JC (2012) Altered fractionated radiotherapy in locally advanced head and neck cancer. Curr Opin Oncol 24:1\u20136","journal-title":"Curr Opin Oncol"},{"issue":"26","key":"925_CR6","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2011.35.7301","volume":"29","author":"BS Rose","year":"2011","unstructured":"Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK (2011) Population-based study of competing mortality in head and neck cancer. J Clin Oncol 29(26):3503\u20133509","journal-title":"J Clin Oncol"},{"key":"925_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2006.03.010","volume":"79","author":"JA Medina","year":"2006","unstructured":"Medina JA, Rueda A, Sachetti A (2006) A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol 79:34\u201338","journal-title":"Radiother Oncol"},{"key":"925_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","volume":"48","author":"KK Fu","year":"2000","unstructured":"Fu KK, Pajack TF, Trotti A et al (2000) A radiation therapy oncology group phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 2003. Int J Radiat Oncol Biol Phys 48:7\u201316","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"925_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214","journal-title":"Cancer"},{"key":"925_CR10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"925_CR11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrc1650","volume":"5","author":"J Kim","year":"2005","unstructured":"Kim J, Tannock I (2005) Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5:516\u2013525","journal-title":"Nat Rev Cancer"},{"key":"925_CR12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","volume":"368","author":"J Bourhis","year":"2006","unstructured":"Bourhis J, Overgaard J, Audry H, Meta-Analysis of Radiotherapy in Carcinomas of Head and Neck (MARCH) Collaborative Group et al (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368:843\u2013854","journal-title":"Lancet"},{"issue":"Suppl 15","key":"925_CR13","doi-asserted-by":"crossref","first-page":"A-5507","DOI":"10.1200\/jco.2010.28.15_suppl.5507","volume":"28","author":"K Ang","year":"2010","unstructured":"Ang K, Zhang Q, Wheeler RH et al (2010) A phase III trial (RTOG 0129) of two radiation\u2013cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome [Abstract]. J Clin Oncol 28(Suppl 15):A-5507","journal-title":"J Clin Oncol"},{"key":"925_CR14","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijrobp.2008.06.836","volume":"72","author":"J Bourhis","year":"2008","unstructured":"Bourhis J, Sire C, Lapeyre M et al (2008) Accelerated versus conventional radiotherapy with concomitant chemotherapy in locally advanced head and neck carcinomas: results of a phase III randomized trial. Int J Radiat Oncol Biol Phys 72:S31\u2013S32","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"925_CR15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jclinepi.2010.10.016","volume":"64","author":"P Blanchard","year":"2011","unstructured":"Blanchard P, Catherine H, Guihenneuc-Jouyaux C (2011) Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer. J Clin Epidemiol 64:985\u2013992","journal-title":"J Clin Epidemiol"},{"key":"925_CR16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1470-2045(08)70098-6","volume":"9","author":"L Veldeman","year":"2008","unstructured":"Veldeman L, Madani I, Hulstaert F, De Meerleer G et al (2008) Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 9:367\u2013375","journal-title":"Lancet Oncol"},{"key":"925_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hed.20495","volume":"29","author":"AM Allen","year":"2007","unstructured":"Allen AM, Elshaikh M, Worden FP et al (2007) Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer. Head Neck 29:137\u2013142","journal-title":"Head Neck"},{"key":"925_CR18","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2005.12.060","volume":"23","author":"KK Ang","year":"2005","unstructured":"Ang KK, Harris J, Garden AS et al (2005) Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol 23:3008\u20133015","journal-title":"J Clin Oncol"},{"key":"925_CR19","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1002\/cncr.25189","volume":"116","author":"HE Newlin","year":"2010","unstructured":"Newlin HE, Amdur RJ, Riggs CE et al (2010) Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer. Cancer 116:4533\u20134540","journal-title":"Cancer"},{"issue":"15","key":"925_CR20","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-03-1077","volume":"10","author":"A Argiris","year":"2004","unstructured":"Argiris A, Brockstein B, Haraf DJ et al (2004) Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10(15):1956\u20131962","journal-title":"Clin Cancer Res"},{"key":"925_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(09)70384-5","volume":"11","author":"J Corry","year":"2010","unstructured":"Corry J, Peters LJ, Rischin D (2010) Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol 11:287\u2013291","journal-title":"Lancet Oncol"},{"issue":"26","key":"925_CR22","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2011.35.7301","volume":"29","author":"B Rose","year":"2011","unstructured":"Rose B, Jong-Hyeon J, Nathe SK (2011) Population based study of competing mortality in head and neck cancer. J Clin Oncol 29(26):3503\u20133509","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0925-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0925-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:53:29Z","timestamp":1562115209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0925-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,22]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0925-9","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,22]]}}}